scholarly article | Q13442814 |
P50 | author | Pavani Garlapati | Q57419064 |
Osama Mukhtar | Q60388560 | ||
Vijay Gayam | Q60388567 | ||
P2093 | author name string | Amrendra Kumar Mandal | |
Arshpal Gill | |||
Mazin Khalid | |||
Mohammed Mansour | |||
Mowyad Khalid | |||
P2860 | cites work | Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis. | Q53118691 |
Non-invasive diagnosis of esophageal varices in chronic liver diseases | Q57782873 | ||
Management of Hepatitis C Post-liver Transplantation: a Comprehensive Review | Q26781741 | ||
Weight loss, leukopenia and thrombocytopenia associated with sustained virologic response to Hepatitis C treatment | Q27490841 | ||
The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection | Q29620318 | ||
Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection | Q29620620 | ||
Prevalence of peripheral blood cytopenias (hypersplenism) in patients with nonalcoholic chronic liver disease | Q33334842 | ||
Review article: thrombocytopenia in chronic liver disease and pharmacologic treatment options | Q33370831 | ||
A review of the treatment of chronic hepatitis C virus infection in cirrhosis | Q33394104 | ||
Current and future therapies for hepatitis C virus infection | Q34036762 | ||
Outcome of sustained virological responders with histologically advanced chronic hepatitis C. | Q34101701 | ||
All-oral 12-week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY-3 phase III study | Q35538245 | ||
Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010 | Q36035889 | ||
Virologic response following combined ledipasvir and sofosbuvir administration in patients with HCV genotype 1 and HIV co-infection | Q38415842 | ||
Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials | Q40251971 | ||
Rising Mortality Associated With Hepatitis C Virus in the United States, 2003-2013. | Q40769735 | ||
Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection | Q40907444 | ||
Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection | Q40908880 | ||
Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS). | Q41429836 | ||
Long-term beneficial effects in sustained responders to interferon-alfa therapy for chronic hepatitis C. | Q43032576 | ||
Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection | Q43807978 | ||
Changes in antipyrine clearance and platelet count, but not conventional liver tests, correlate with fibrotic change in chronic hepatitis C: value for predicting fibrotic progression | Q44485400 | ||
Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus. METAVIR and CLINIVIR Cooperative Study Groups | Q45762654 | ||
Long-term monitoring of platelet count, as a non-invasive marker of hepatic fibrosis progression and/or regression in patients with chronic hepatitis C after interferon therapy | Q46929729 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | liver cirrhosis | Q147778 |
sofosbuvir | Q2502747 | ||
chronic hepatitis C | Q55779873 | ||
P304 | page(s) | 4136253 | |
P577 | publication date | 2018-01-01 | |
P1433 | published in | International Journal of Hepatology | Q26853849 |
P1476 | title | Sofosbuvir Based Regimens in the Treatment of Chronic Hepatitis C with Compensated Liver Cirrhosis in Community Care Setting | |
P478 | volume | 2018 |
Search more.